FDA approves Roche drug for non-small cell lung cancer
The U.S. Food and Drug Administration has approved Roche’s Tecentriq as adjuvant treatment fol...
Roche, Novartis approvals in Europe signal more head-to-head competition
FILE PHOTO: A sign at a diagnostics site for Swiss...
